CohBar Inc CWBR:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/30/22 EDT
2.88quote price arrow down-0.09 (-3.03%)
Volume
16,293
52 week range
2.71 - 30.90
Loading...
  • Open2.88
  • Day High3.08
  • Day Low2.84
  • Prev Close2.97
  • 52 Week High30.90
  • 52 Week High Date10/07/21
  • 52 Week Low2.71
  • 52 Week Low Date09/26/22

Key Stats

  • Market Cap8.38M
  • Shares Out2.91M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta2.26
  • YTD % Change-72.56

KEY STATS

  • Open2.88
  • Day High3.08
  • Day Low2.84
  • Prev Close2.97
  • 52 Week High30.90
  • 52 Week High Date10/07/21
  • 52 Week Low2.71
  • 52 Week Low Date09/26/22
  • Market Cap8.38M
  • Shares Out2.91M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta2.26
  • YTD % Change-72.56

RATIOS/PROFITABILITY

  • EPS (TTM)-4.73
  • P/E (TTM)-0.61
  • Fwd P/E (NTM)-36.00
  • EBITDA (TTM)-12.054M
  • ROE (TTM)-74.25%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/14/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CohBar Inc

 

Profile

MORE
CohBar, Inc. is a clinical-stage biotechnology company. The Company focuses on developing therapeutics targeting chronic and age-related diseases. It is advancing a pipeline of peptide analogs through varying stages of development, such as CB5138-3 for idiopathic pulmonary fibrosis (IPF); CB4211 for the treatment of non-alcoholic steatohepatitis (NASH) and obesity; and several preclinical and discovery-stage programs. Its processes of identifying nucleic acid sequences...
David Greenwood
Independent Chairman of the Board
Joseph Sarret M.D., J.D.
Chief Executive Officer, Director
Jeffrey Biunno CPA
Chief Financial Officer, Treasurer, Secretary
Address
1455 Adams Drive, Suite 2050
Menlo Park, CA
94025
United States

Top Peers

SYMBOLLASTCHG%CHG
BTI
British American Tobacco PLC
35.50-0.48-1.33%
KTRA
Kintara Therapeutics Inc
0.108-0.0059-5.18%
APLI
LMNL
Liminal BioSciences Inc
0.42UNCHUNCH
EDSA
Edesa Biotech Inc
0.9213-0.4987-35.1197%